Arcus Biosciences (RCUS) Share-based Compensation Growth (3y) (2020 - 2026)
Arcus Biosciences (RCUS) Share-based Compensation Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -50.27% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -0.04% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 38.45% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Arcus Biosciences | 3.57 Bn | 2.75 Bn | - | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | -4.09% |
| Sep 30, 2025 | -4.87% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | -2.00% |
| Dec 31, 2024 | -29.53% |
| Sep 30, 2024 | -59.07% |
| Jun 30, 2024 | -50.68% |
| Mar 31, 2024 | 16.16% |
| Sep 30, 2023 | -101.36% |
| Jun 30, 2023 | 59.09% |
| Mar 31, 2023 | 76.39% |
| Dec 31, 2022 | 91.07% |
| Sep 30, 2022 | 81.05% |
| Jun 30, 2022 | 91.68% |
| Mar 31, 2022 | 116.55% |
| Dec 31, 2021 | 138.43% |
| Sep 30, 2021 | 140.54% |
| Jun 30, 2021 | 128.80% |
| Mar 31, 2021 | 168.94% |